Výsledky vyhledávání - "E. H. Gerlach"

Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium

Autor: M E Erwin, Gary V. Doern, Janet F. Hindler, E. H. Gerlach, R N Jones

Publikováno v: Diagnostic Microbiology and Infectious Disease. 18:243-249

Some recently marketed macrolide antimicrobial agents possess physiochemical, antimicrobial, and pharmacokinetic advantages that enable their wider clinical use against Haemophilus influenzae infections. A five-laboratory study assessed the validity

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3c66dd3bc50b3a94600e07c71549d7f9
https://doi.org/10.1016/0732-8893(94)90027-2

Zobrazit plný text záznamu

In-vitro activity of five β-lactam/β-lactamase inhibitor combinations against consecutive isolates of the Enterobacteriaceae and Pseudomonas aeruginosa

Autor: Peter C. Fuchs, J. C. McLaughlin, Dwight J. Hardy, M. A. Pfaller, Arthur L. Barry, E. H. Gerlach

Publikováno v: Journal of Antimicrobial Chemotherapy. 33:223-230

Susceptibility tests were performed on 2402 of consecutive isolates of Enterobacteriaceae and 254 strains of Pseudomonas aeruginosa in five separate medical centres. Five beta-lactams were evaluated with and without a beta-lactamase inhibitor. The ef

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ccea3400ccf30c29ca87fafe35ed96d
https://doi.org/10.1093/jac/33.2.223

Zobrazit plný text záznamu

In VittoComparison Activity ofOPC-17116, a New Fluoroquinolone, Against More Than 5,000 Recent Clinical Isolates from Five Medical Centers

Autor: Stephen D. Allen, Patrick R. Murray, E. H. Gerlach, Ronald N. Jones, John A. Washington, Helio S. Sader

Publikováno v: Journal of Chemotherapy. 5:283-288

The in vitro activity of OPC-17116, a new fluoroquinolone, was compared with those of ciprofloxacin, ofloxacin and cefixime. A total of 5,231 fresh clinical isolates from five geographically separate US medical centers were tested. The primary result

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03362931fa95718237e3163cdbcd08fb
https://doi.org/10.1080/1120009x.1993.11739245

Zobrazit plný text záznamu

Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamine

Autor: Fred C. Tenover, Stephen D. Allen, Dwight J. Hardy, M. A. Pfaller, Arthur L. Barry, E H Gerlach, L B Reller, Peter C. Fuchs

Publikováno v: European Journal of Clinical Microbiology & Infectious Diseases. 12:352-356

Studies with fosfomycin tromethamine disks containing 200 micrograms of fosfomycin and 50 micrograms of glucose-6-phosphate confirmed the following zone diameter criteria for the NCCLS method:or = 12 mm for resistant (MICor = 256 micrograms/ml), 13-1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5344b26d673e2e13383e9543f1cecb1b
https://doi.org/10.1007/bf01964433

Zobrazit plný text záznamu

Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates ofEnterobacteriaceae

Autor: Arthur L. Barry, E H Gerlach, M. A. Pfaller, Peter C. Fuchs, J. C. McLaughlin, Dwight J. Hardy

Publikováno v: European Journal of Clinical Microbiology & Infectious Diseases. 12:200-205

Three beta-lactamase inhibitors were combined with ampicillin in a fixed 2:1 ratio. The activity of ampicillin was enhanced by tazobactam and by clavulanic acid, and to a lesser extent by sulbactam when tested against fresh clinical isolates of Enter

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::388a28e15d46078bd2e4f7d105f1c052
https://doi.org/10.1007/bf01967112

Zobrazit plný text záznamu

In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolates

Autor: F P Koontz, Michael A. Pfaller, John A. Washington, R. N. Jones, S D Allen, M E Erwin, P R Murray, E. H. Gerlach

Publikováno v: Antimicrobial Agents and Chemotherapy. 35:1508-1511

The activity of GR69153, a novel catechol-substituted cephalosporin, was compared with those of ceftazidime and ceftriaxone in a multicenter study against 5,203 fresh clinical isolates of gram-negative and gram-positive bacteria. GR69153 was generall

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6533926084745f8a94b4e3ded1f9ceab
https://doi.org/10.1128/aac.35.7.1508

Zobrazit plný text záznamu

Interpretive criteria and quality control guidelines for Neisseria gonorrhoeae susceptibility test standardization for cefotetan

Autor: C. C. Knapp, M. A. Pfaller, Franklin P. Koontz, E H Gerlach, R N Jones, P R Murray, M E Erwin, J A Washington

Publikováno v: Journal of Clinical Microbiology. 29:363-366

Cefotetan was tested in a multilaboratory study to standardize susceptibility testing criteria and quality control guidelines for Neisseria gonorrhoeae. Cefotetan was most active against penicillinase-producing and penicillin-susceptible strains (MIC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcba3e0c121eaf5e5fe40b1c746a42b4
https://doi.org/10.1128/jcm.29.2.363-366.1991

Zobrazit plný text záznamu

Multilaboratory Evaluation of an Agar Diffusion Disk Susceptibility Test for Rapidly Growing Anaerobic Bacteria

Autor: G. S. Hall, J. D. Williams, J. Wüst, A L Barry, Peter C. Fuchs, Jacques F. Acar, A.-M. Bourgault, H. Grimm, Kenneth E. Aldridge, E H Gerlach, Jana M. Swenson, Clyde Thornsberry, R N Jones, W. Heizmann, Hannah M. Wexler, Stephen D. Allen

Publikováno v: Clinical Infectious Diseases. 12:S210-S217

A multilaboratory collaborative study was undertaken to determine whether the anaerobic disk diffusion test of Horn et al. could be performed reproducibly and accurately. Tests with nine different antimicrobial disks were evaluated. Reproducibility o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b34261f2df7bc49a735a087c701db171
https://doi.org/10.1093/clinids/12.supplement_2.s210

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání